What is Nucelis?
Nucelis is a prominent player in precision gene editing, leveraging its proprietary Rapid Trait Development System (RTDS) to drive advancements in sustainable agriculture. The company specializes in creating non-transgenic, gene-edited traits designed to boost crop productivity and foster the development of sustainable ingredients. Nucelis aims to equip agricultural producers and large food industry corporations with tools to navigate environmental challenges, reducing reliance on chemicals and minimizing ecological impact. Through its cutting-edge plant breeding techniques, Nucelis is set to redefine the agricultural landscape, delivering products that are functionally equivalent to those developed via conventional methods.
How much funding has Nucelis raised?
Nucelis has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Nucelis
PPP
Public-Private Partnership
What's next for Nucelis?
With substantial late-stage funding, Nucelis is strategically positioned for accelerated growth and market expansion. The recent major strategic investment signals strong confidence from backers in the company's technology and its potential to disrupt traditional agricultural practices. This capital infusion will likely fuel further research and development, enhance production capabilities, and broaden Nucelis's market reach. The company's focus on sustainable and efficient crop solutions aligns with global trends towards environmentally conscious agriculture, suggesting a promising trajectory for future innovation and commercial success.
See full Nucelis company page
